Patents by Inventor Cynthia C. Bamdad

Cynthia C. Bamdad has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10421819
    Abstract: The present describes monoclonal antibody to MUC1*.
    Type: Grant
    Filed: October 6, 2009
    Date of Patent: September 24, 2019
    Assignee: Minerva Biotechnologies Corporation
    Inventors: Cynthia C. Bamdad, Sanjeev Mahanta
  • Publication number: 20180222998
    Abstract: The present describes monoclonal antibody to MUC1*.
    Type: Application
    Filed: October 6, 2009
    Publication date: August 9, 2018
    Applicant: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia C. BAMDAD, Sanjeev MAHANTA
  • Patent number: 10042088
    Abstract: The present invention relates generally to optical materials and applications of optical materials and, more particularly, to optical materials incorporating particles such as nanoparticles, methods of forming such materials, and applications of such materials in various devices, for example, for filters, displays, coatings for glare reduction, and the like. The present invention can provide control over fabrication dimensions at very small scale, for example, at the molecular scale rather than at a macroscopic scale. The invention also involves, in some cases, controlling the interaction of many wavelengths of electromagnetic radiation with these materials. The optical materials and devices of the invention may be constructed and arranged for a response to, control of, and/or interaction with essentially any electromagnetic radiation, electric field, and/or magnetic field.
    Type: Grant
    Filed: June 20, 2005
    Date of Patent: August 7, 2018
    Assignee: Minerva Biotechnologies Corporation
    Inventor: Cynthia C. Bamdad
  • Publication number: 20170204191
    Abstract: The present describes monoclonal antibody to MUC1*.
    Type: Application
    Filed: October 6, 2009
    Publication date: July 20, 2017
    Inventors: Cynthia C. BAMDAD, Sanjeev Mahanta
  • Patent number: 8859495
    Abstract: The present application discloses a method for stimulating or enhancing proliferation of a population of cells by activating MUC1 receptor on the cells.
    Type: Grant
    Filed: March 30, 2006
    Date of Patent: October 14, 2014
    Assignee: Minerva Biotechnologies Corporation
    Inventor: Cynthia C. Bamdad
  • Publication number: 20140021066
    Abstract: The invention relates to the use of particles comprising binding ligands and electron transfer moieties (ETMs). Upon binding of a target analyte, a particle and a reporter composition are associated and transported to an electrode surface. The ETMs are then detected, allowing the presence or absence of the target analyte to be determined.
    Type: Application
    Filed: July 10, 2013
    Publication date: January 23, 2014
    Applicant: Osmetech Technology Inc.
    Inventors: Cynthia C. BAMDAD, Robert C. Mucic
  • Patent number: 8535944
    Abstract: The present application describes a method of culturing, expanding or growing stem or stem-like cells or induced pluripotent stem cells on a surface, including attaching the cells to the surface through a ligand that binds to the surface and the cells.
    Type: Grant
    Filed: June 11, 2010
    Date of Patent: September 17, 2013
    Assignee: Minerva Biotechnologies Corporation
    Inventor: Cynthia C. Bamdad
  • Patent number: 8501921
    Abstract: The invention relates to the use of particles comprising binding ligands and electron transfer moieties (ETMs). Upon binding of a target analyte, a particle and a reporter composition are associated and transported to an electrode surface. The ETMs are then detected, allowing the presence or absence of the target analyte to be determined.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: August 6, 2013
    Assignee: Osmetech Technology, Inc.
    Inventors: Cynthia C. Bamdad, Robert C. Mucic
  • Patent number: 8349853
    Abstract: This invention generally relates to compositions and methods for cancer treatment and, in particular, to compositions able to interact (e.g., bind to) with MUC1 growth factor receptor or its ligands, and methods for treating the same. The invention also relates to assays or use of such compositions for the treatment of patients susceptible to or exhibiting symptoms characteristic of cancer or tumorigenesis. Other compositions of the present invention useful for the treatment or prevention of cancer or tumorigenesis include homologs, analogs, derivatives, enantiomers or functional equivalents. The present compositions can also be packaged in kits in some cases.
    Type: Grant
    Filed: September 5, 2002
    Date of Patent: January 8, 2013
    Assignee: Minerva Biotechnologies Corporation
    Inventor: Cynthia C. Bamdad
  • Patent number: 8344113
    Abstract: The invention provides a series of compositions, methods, kits, articles and species associated primarily with the diagnosis and/or treatment of cell proliferation, specifically cancer. Cell proliferation associated with aberrant expression of MUC1 is particularly focused upon. Mechanisms associated with MUC1 cell proliferation are discussed.
    Type: Grant
    Filed: January 27, 2010
    Date of Patent: January 1, 2013
    Assignee: Minerva Biotechnologies Corporation
    Inventor: Cynthia C. Bamdad
  • Publication number: 20120156246
    Abstract: The present application describes a method of treating a patient with cancer or at risk of developing cancer with at least one regulatory element that induces differentiation of cells.
    Type: Application
    Filed: June 16, 2011
    Publication date: June 21, 2012
    Inventor: CYNTHIA C. BAMDAD
  • Publication number: 20120135530
    Abstract: The invention relates to the use of particles comprising binding ligands and electron transfer moieties (ETMs). Upon binding of a target analyte, a particle and a reporter composition are associated and transported to an electrode surface. The ETMs are then detected, allowing the presence or absence of the target analyte to be determined.
    Type: Application
    Filed: October 31, 2007
    Publication date: May 31, 2012
    Applicant: Clinical Micro Sensors, Inc.
    Inventors: Cynthia C. Bamdad, Robert C. Mucic
  • Publication number: 20110250616
    Abstract: The invention provides compositions, kits, methods, and species that include electroactive entities which can serve as signaling entities in chemical and/or biochemical assays. The electroactive species can be metallocenes, such as ferrocenes, including substituents that affect the oxidation/reduction potential (redox potential) of the species. By controlling the redox potential of the species, multiple species can be used in a single assay, each species having a different redox potential, for simultaneous signaling of different binding events. Additionally, species having redox potentials lower than 490 mV can be provided, allowing signaling within a potential range easily detectable in the presence of biological fluids.
    Type: Application
    Filed: June 20, 2011
    Publication date: October 13, 2011
    Inventors: Cynthia C. BAMDAD, Shoshana Bamdad Shendelman, Michael Frid
  • Patent number: 8012743
    Abstract: The invention relates to the use of particles comprising binding ligands and electron transfer moieties (ETMs). Upon binding of a target analyte, a particle and a reporter composition are associated and transported to an electrode surface. The ETMs are then detected, allowing the presence or absence of the target analyte to be determined.
    Type: Grant
    Filed: December 10, 2001
    Date of Patent: September 6, 2011
    Assignee: Osmetech Technology Inc.
    Inventors: Cynthia C. Bamdad, Robert C. Mucic
  • Publication number: 20110053788
    Abstract: The invention relates to the use of particles comprising binding ligands and electron transfer moieties (ETMs). Upon binding of a target analyte, a particle and a reporter composition are associated and transported to an electrode surface. The ETMs are then detected, allowing the presence or absence of the target analyte to be determined.
    Type: Application
    Filed: December 10, 2001
    Publication date: March 3, 2011
    Inventors: Cynthia C. Bamdad, Robert C. Mucic
  • Publication number: 20100316688
    Abstract: The present application describes a method of culturing, expanding or growing stem or stem-like cells or induced pluripotent stem cells on a surface, including attaching the cells to the surface through a ligand that binds to the surface and the cells.
    Type: Application
    Filed: June 11, 2010
    Publication date: December 16, 2010
    Inventor: Cynthia C. Bamdad
  • Publication number: 20100136017
    Abstract: The invention provides a series of compositions, methods, kits, articles and species associated primarily with the diagnosis and/or treatment of cell proliferation, specifically cancer. Cell proliferation associated with aberrant expression of MUC1 is particularly focused upon. Mechanisms associated with MUC1 cell proliferation are discussed.
    Type: Application
    Filed: January 27, 2010
    Publication date: June 3, 2010
    Inventor: Cynthia C. BAMDAD
  • Publication number: 20100124789
    Abstract: Porous members can be positioned so as to partially or fully span channels in microfluidic systems. The porous members can be assembled and/or disassembled in situ. The porous members can be made such that pores are separated by connections including but a single molecule at one location, allowing for a high level of open area in a very small pore size member. The porous member can be made up of colloid particles interconnected with molecular species. These can be used to detect analytes qualitatively and/or quantitatively, or to selectively bind and/or release agents on command for a variety of purposes including first blocking, then opening a channel, concentrating analyte over time followed by release of analyte and detection downstream, etc. Porous members can define valves in multiple-channel systems and, with controlled binding and release of agents at the porous members, these valves can be opened and closed and fluid flow controlled in a multi-channel system.
    Type: Application
    Filed: November 5, 2009
    Publication date: May 20, 2010
    Applicant: Minerva Biotechnologies Corporation
    Inventor: Cynthia C. BAMDAD
  • Patent number: 7700715
    Abstract: The invention provides a series of compositions, methods, kits, articles and species associated primarily with the diagnosis and/or treatment of cell proliferation, specifically cancer. Cell proliferation associated with aberrant expression of MUC1 is particularly focused upon. Mechanisms associated with MUC1 cell proliferation are discussed.
    Type: Grant
    Filed: November 27, 2001
    Date of Patent: April 20, 2010
    Assignee: Minerva Biotechnologies Corporation
    Inventors: Cynthia C. Bamdad, R. Shoshana Bamdad
  • Publication number: 20100093092
    Abstract: The present application describes a method for inducing or maintaining pluripotency in a cell by contacting the cell with a biological or chemical species that increases MUC1* activity.
    Type: Application
    Filed: October 9, 2009
    Publication date: April 15, 2010
    Inventors: Cynthia C. BAMDAD, Shawn P. Fessler